Newsroom

Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple-negative breast cancer

December 10, 2015

MD Anderson study identifies socio-demographic factors contributing to delayed treatment

MD Anderson News Release 12/10/2015

Postponing the start of adjuvant chemotherapy for more than 90 days following surgery may significantly increase risk of death for breast cancer patients, particularly those with triple-negative breast cancer (TNBC), according to a new study from The University of Texas MD Anderson Cancer...

Everolimus improves progression-free survival for patients with advanced, nonfunctional neuroendocrine tumors of the lung, gastrointestinal tract

BY Tyler Hill

September 26, 2015

MD Anderson led research in field, from small investigator-initiated studies to international confirmatory trials

MD Anderson News...

Breakthrough study demonstrates survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients

BY Tyler Hill

September 25, 2015

CheckMate-025 study led by The University of Texas MD Anderson Cancer Center portends paradigm change in standard of care treatment...

MD Anderson study identifies leukemia tumor suppressor

September 24, 2015

Protein-coding gene hnRNP K may be culprit in acute myeloid leukemia

MD Anderson News Release 09/24/2015

A protein-coding gene called hnRNP K has been identified as a tumor suppressor for acute myeloid leukemia (AML), a finding that could be important for investigating how best to target treatment of a blood cancer striking mostly older individuals.

Expression of the protein-coding gene hnRNP K is significantly...